TABLE 2.
Pearson correlation coefficients between the changes in different metabolic, cardiovascular, and PA markers (post–pre Δ values) during the intervention.
| Δ MetS score | Δ WC, cm | Δ BMI, kg·m−2 | Δ Body Mass, kg | Δ Body Fat % | Δ FFM, kg | Δ M-Value | Δ fInsulin, mU·L−1 | Δ fGlucose, mmol·L−1 | Δ HbA1c, mmol·L−1 | Δ Energy Intake, kJ | Δ Energy Intake, kJ·kg−1 | Δ SB % | Δ Standing % | Δ LPA % | Δ MVPA % | Δ Steps per Day | Δ Breaks in SB per Day | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Δ MetS score | 1 | 0.32* | 0.35* | 0.36** | −0.06 | 0.24 | −0.30* | 0.51** | 0.55** | 0.10 | 0.21 | 0.15 | −0.03 | 0.17 | −0.09 | −0.12 | −0.15 | −0.02 |
| Δ WC, cm | 1 | 0.53** | 0.54** | 0.13 | 0.16 | −0.23 | 0.20 | 0.10 | 0.24 | 0.25 | 0.19 | 0.09 | 0.18 | −0.25 | −0.29* | −0.30* | −0.03 | |
| Δ BMI, kg·m−2 | 1 | 1.00** | 0.22 | 0.30* | −0.45** | 0.21 | 0.23 | 0.31* | 0.32* | 0.19 | 0.27 | −0.10 | −0.37** | −0.19 | −0.23 | −0.19 | ||
| Δ Body mass, kg | 1 | 0.22 | 0.30* | −0.44** | 0.23 | 0.23 | 0.32* | 0.33* | 0.19 | 0.27 | −0.11 | −0.37** | −0.17 | −0.22 | −0.18 | |||
| Δ Body fat % | 1 | −0.85** | −0.03 | −0.02 | 0.01 | 0.15 | 0.01 | 0.00 | 0.12 | −0.21 | 0.09 | −0.07 | −0.12 | −0.22 | ||||
| Δ FFM, kg | 1 | −0.21 | 0.18 | 0.14 | −0.01 | 0.19 | 0.13 | 0.01 | 0.17 | −0.28* | −0.04 | −0.01 | 0.08 | |||||
| Δ M-value | 1 | −0.22 | −0.32* | −0.11 | −0.19 | −0.13 | −0.31* | 0.24 | 0.26 | 0.17 | 0.19 | 0.02 | ||||||
| Δ fInsulin, mU·L−1 | 1 | 0.23 | 0.18 | 0.15 | 0.10 | 0.17 | −0.22 | −0.07 | −0.02 | −0.09 | −0.08 | |||||||
| Δ fGlucose, mmol·L−1 | 1 | 0.11 | 0.49** | 0.51** | 0.00 | 0.13 | −0.16 | −0.03 | −0.17 | −0.27 | ||||||||
| Δ HbA1c, mmol·L−1 | 1 | 0.01 | −0.02 | 0.16 | 0.00 | −0.14 | −0.28* | −0.32* | −0.17 | |||||||||
| Δ Energy intake, kJ | 1 | 0.97** | −0.08 | 0.12 | 0.05 | −0.03 | −0.13 | −0.09 | ||||||||||
| Δ Energy intake, kJ·kg−1 | 1 | −0.13 | 0.17 | 0.05 | 0.01 | −0.10 | −0.08 | |||||||||||
| Δ SB % | 1 | −0.79*** | −0.69** | −0.69** | −0.55** | −0.38** | ||||||||||||
| Δ Standing % | 1 | 0.24 | 0.25 | 0.20 | 0.17 | |||||||||||||
| Δ LPA % | 1 | 0.46** | 0.37** | 0.35** | ||||||||||||||
| Δ MVPA % | 1 | 0.79** | 0.39** | |||||||||||||||
| Δ Steps per day | 1 | 0.48** | ||||||||||||||||
| Δ Breaks in SB per day | 1 |
Δ, the change from preintervention to postintervention measurements in metabolic and cardiovascular outcomes, and from screening to intervention in accelerometry outcomes; fInsulin, fasting plasma insulin, fGlucose, fasting plasma glucose; LPA, LPA measured by accelerometry; MetS score, MetS severity score (sum of waist circumference, mean blood pressure, fasting plasma glucose, insulin, and HDL/triglyceride-ratio); M-value, whole-body insulin-stimulated GU measured by HEC; MVPA, MVPA measured by accelerometry; SB, SB measured by accelerometry; WC, waist circumference.
*Significant at the level of P < 0.05.
**Significant at the level of P < 0.01.